| Interrater agreement and interrater reliability: key concepts, approaches, and applications N Gisev, JS Bell, TF Chen Research in Social and Administrative Pharmacy 9 (3), 330-338, 2013 | 817 | 2013 |
| A synthesis of oral morphine equivalents (OME) for opioid utilisation studies S Nielsen, L Degenhardt, B Hoban, N Gisev Pharmacoepidemiology and drug safety 25 (6), 733-737, 2016 | 407 | 2016 |
| New psychoactive substances: challenges for drug surveillance, control, and public health responses A Peacock, R Bruno, N Gisev, L Degenhardt, W Hall, R Sedefov, J White, ... The Lancet 394 (10209), 1668-1684, 2019 | 259 | 2019 |
| The impact of opioid substitution therapy on mortality post‐release from prison: retrospective data linkage study L Degenhardt, S Larney, J Kimber, N Gisev, M Farrell, T Dobbins, ... Addiction 109 (8), 1306-1317, 2014 | 253 | 2014 |
| Trends in heroin and pharmaceutical opioid overdose deaths in Australia A Roxburgh, WD Hall, T Dobbins, N Gisev, L Burns, S Pearson, ... Drug and alcohol dependence 179, 291-298, 2017 | 169 | 2017 |
| Prevalence and incidence of prescription opioid analgesic use in Australia S Lalic, J Ilomäki, JS Bell, MJ Korhonen, N Gisev British journal of clinical pharmacology 85 (1), 202-215, 2019 | 115 | 2019 |
| Opioid substitution therapy as a strategy to reduce deaths in prison: retrospective cohort study S Larney, N Gisev, M Farrell, T Dobbins, L Burns, A Gibson, J Kimber, ... BMJ open 4 (4), e004666, 2014 | 93 | 2014 |
| Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research S Nielsen, L Degenhardt, B Hoban, N Gisev National Drug and Alcohol Research Centre, 2014 | 88 | 2014 |
| The extent and correlates of community‐based pharmaceutical opioid utilisation in Australia L Degenhardt, N Gisev, E Cama, S Nielsen, B Larance, R Bruno Pharmacoepidemiology and Drug Safety 25 (5), 521-538, 2016 | 85 | 2016 |
| A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia L Burns, N Gisev, S Larney, T Dobbins, A Gibson, J Kimber, B Larance, ... Addiction 110 (4), 646-655, 2015 | 85 | 2015 |
| Predictors of persistent prescription opioid analgesic use among people without cancer in Australia S Lalic, N Gisev, JS Bell, MJ Korhonen, J Ilomäki British journal of clinical pharmacology 84 (6), 1267-1278, 2018 | 83 | 2018 |
| An expert panel assessment of comprehensive medication reviews for clients of community mental health teams N Gisev, JS Bell, CL O’Reilly, A Rosen, TF Chen Social psychiatry and psychiatric epidemiology 45, 1071-1079, 2010 | 73 | 2010 |
| Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis T Santo Jr, G Campbell, N Gisev, D Martino-Burke, J Wilson, ... Drug and Alcohol Dependence 238, 109551, 2022 | 65 | 2022 |
| Prevalence of childhood maltreatment among people with opioid use disorder: A systematic review and meta-analysis T Santo Jr, G Campbell, N Gisev, LT Tran, S Colledge, GL Di Tanna, ... Drug and alcohol dependence 219, 108459, 2021 | 57 | 2021 |
| Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatment S Nielsen, N Gisev, R Bruno, W Hall, M Cohen, B Larance, G Campbell, ... Pharmacoepidemiology and drug safety 26 (5), 587-591, 2017 | 55 | 2017 |
| To what extent do data from pharmaceutical claims under‐estimate opioid analgesic utilisation in Australia? N Gisev, SA Pearson, EA Karanges, B Larance, NA Buckley, S Larney, ... Pharmacoepidemiology and drug safety 27 (5), 550-555, 2018 | 47 | 2018 |
| Pharmaceutical opioid use and harm in Australia: the need for proactive and preventative responses B Larance, L Degenhardt, A Peacock, N Gisev, R Mattick, S Colledge, ... Drug and Alcohol Review 37, S203-S205, 2018 | 44 | 2018 |
| An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia N Gisev, S Nielsen, E Cama, B Larance, R Bruno, L Degenhardt European journal of clinical pharmacology 72, 469-494, 2016 | 43 | 2016 |
| The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study N Gisev, C Bharat, S Larney, T Dobbins, D Weatherburn, M Hickman, ... The Lancet Public Health 4 (7), e334-e342, 2019 | 42 | 2019 |
| Engagement with the criminal justice system among opioid‐dependent people: A retrospective cohort study L Degenhardt, N Gisev, J Trevena, S Larney, J Kimber, L Burns, ... Addiction 108 (12), 2152-2165, 2013 | 37 | 2013 |
